MoneyWorks4Me

MPS Pharmaa - Quaterly Results

03 Feb 2026 Evaluate
The revenue for the December 2025 quarter is pegged at Rs. 0.00 millions against Rs. 0.00 millions recorded during the year-ago period.The Net Loss for the quarter ended December 2025 is Rs. -2.21 millions as compared to Net Loss of Rs. -1.75 millions of corresponding quarter ended December 2024 Operating profit Margin for the quarter ended December 2025 further decreased to -1.93% as compared to -1.41% of corresponding quarter ended December 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 0.00 0.44 0.00 0.00 0.48 0.00 0.48 0.94 -48.94
PBIDT -1.93 -1.41 36.88 -5.78 -5.25 10.10 -7.17 -7.05 1.70
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.00
PBDT -1.93 -1.41 36.88 -5.78 -5.25 10.10 -7.18 -7.06 1.70
Depreciation 0.37 0.37 0.00 1.11 1.11 0.00 1.47 1.47 0.00
PBT -2.30 -1.78 29.21 -6.89 -6.36 8.33 -8.65 -8.53 1.41
TAX -0.09 -0.03 200.00 -0.28 -0.16 75.00 0.34 -0.22 -254.55
Deferred Tax -0.09 -0.03 200.00 -0.28 -0.16 75.00 0.00 -0.22 -100.00
PAT -2.21 -1.75 26.29 -6.61 -6.20 6.61 -8.99 -8.31 8.18
Equity 191.11 191.11 0.00 191.11 191.11 0.00 191.11 191.11 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..